Trials / Sponsors / Gitte Moos Knudsen
Gitte Moos Knudsen
Academic / Other · 8 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Precision Medicine in the Treatment of Epilepsy Epilepsy | — | 2022-02-18 |
| Terminated | Prophylactic Effects of Psilocybin on Chronic Cluster Headache Cluster Headache | Phase 1 / Phase 2 | 2020-01-21 |
| Completed | Effects of Sleep Deprivation and Adrenergic Inhibition on Glymphatic Flow in Humans Sleep Deprivation, Sleep Wake Disorders, Sleep | EARLY_Phase 1 | 2018-08-28 |
| Recruiting | The Neurobiological Effect of 5-HT2AR Modulation Basic Science | Phase 1 | 2017-03-03 |
| Terminated | Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation Healthy Volunteers | Phase 1 | 2016-09-01 |
| Completed | [11C]Cimbi-36 Dosimetry Healthy | Phase 1 | 2015-12-01 |
| Completed | Evaluation of [11C]Cimbi-36 as an Agonist PET Radioligand for Imaging of 5-HT2A Receptors Healthy | N/A | 2013-01-01 |
| Completed | Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for Depres Postpartum Depression, Major Depressive Disorder, Postpartum Psychosis | N/A | 2011-01-01 |